Introduction
Sarcoidosis is a multisystem disease of unknown etiology characterized by a granulomatous inflammatory process (1, 2) . It is generally assumed that the pathogenesis of the disease results from genetically susceptible hosts being exposed to particular environmental stimuli. Postulated environmental stimuli include infectious agents and noninfectious environmental factors. The fact that there have been numerous reports of familial clustering of this disease indicates that genetic predisposition plays an important role (3) . The presence of noncaesating granulomas is a feature of sarcoidosis and 90% of patients have pulmonary symptoms (4, 5) . The primary manifestation of this disease is an accumulation of mononuclear inflammatory cells, mostly activated CD4 + Th1 T lymphocytes, which produce interleukin (IL)-2 and interferon (IFN)-(6-9).
IL-18 plays an important role in the Th1 response by up-regulating IFN-in synergy
with IL-12 (10, 11) . IL-18 is primarily a monocyte/macrophage-derived cytokine (12) but is also expressed in dendritic cells, Kupffer cells, keratinocytes, synovial fibroblasts, epithelial cells and osteoblasts (13) . IL-18 and its receptor have been shown to be present in elevated levels in the lungs of sarcoidosis patients (14) (15) (16) (17) . It is also an important factor in the regulation of IL-2 expression by pulmonary CD4 + T lymphocytes through AP-1 and NF -Bmediated signaling pathways (17) .
Mutations in the regulatory regions of cytokine genes have been associated with susceptibility to an increasing number of complex diseases. One such mutation is found in the IL-18 5' untranslated region (UTR) promoter (18). The single nucleotide polymorphism (SNP) -607 C/A is predicted to be located at a binding site for cyclic (Adenosine 3', 5'-cyclicmonophosphate) AMP-responsive element-binding protein, CREB (19) . At this position a change from C (cytosine) to A (adenine) nucleotide will disrupt a putative CREB-binding site. Previous studies have shown that this SNP is associated with diabetes, necrotizing 3 enterocolitis, rheumatoid arthritis, the development of post-injury sepsis and also with sarcoidosis (20) (21) (22) (23) (24) .
To further understand the role of IL-18 in sarcoidosis we examined the effect of various stimuli and genetic factors on the expression of IL-18. We found that incubation of monocytes with active sarcoid epithelial lining fluid (ELF) increased IL-18 levels significantly, while incubation with ELF from recovered sarcoid patients did not. We examined IL-18, IL-12 and IFN levels in active sarcoid, recovered patient ELF and controls and found elevated cytokine concentrations in patients with active sarcoidosis. The most striking data was observed during endotoxin analysis of ELF where it was found that sarcoid ELF contained significantly higher levels than normal subject or recovered patient ELF. 
Methods

Study population
Informed consent for BAL fluid collection, using a protocol approved by the Ethics Committee of Beaumont Hospital was obtained from 11 biopsy-proven sarcoidosis patientsstage (54.5%) or (45.5%) -, 6 recovered sarcoidosis patients and 11 non-smoking controls.
Patient and control subject data are presented in Table 1 . Recovered sarcoid patients had clinical and radiological data consistent with quiescence of active disease, either recovering spontaneously or following treatment with prednisolone and had a mean duration of disease of <17.6+/-3.1 months and a minimum of 3 months off corticosteroid treatment. Active patients that did not recover had a mean duration of disease of >27.8+/-4.6 months. BAL was performed as described previously (27) . Volume of ELF recovered was quantified using the urea dilution method as described (28) . These were 1.11 ± 0.03ml for the sarcoid group, 1.15 ± 0.03ml for the recovered group and 0.766 ± 0.02ml for the normal group (mean ± SEM).
Archived BAL fluid from a further 15 sarcoid patients (17) was used for the PCR analyses.
An homogenous Irish population was investigated for the -607 A/C mutation -94 sarcoidosis patients (stage 0, , , or ) and 97 healthy controls (male-female ratio, 61:33 and 42:55; mean age ± SEM 39 ± 3.6 and 75 ± 4.0, respectively) BAL fluid from nine individuals with chronic obstructive pulmonary disease (COPD, 4 males, 5 females, FEV1 50 +/-6 % predicted) was also evaluated for IL-18 levels.
Cell Culture
Human THP-1 monocytic cells were cultured in RPMI 1640 containing 10% FCS, 2 mM L-glutamine, penicillin and streptomycin (Life Technologies, Paisley, U.K.). (Figure 1a , b, c). We also evaluated IL-18 levels in ELF from nine individuals with chronic obstructive pulmonary disease (COPD), a condition associated with Gramnegative infection. Levels of IL-18 in COPD ELF were similar to active sarcoid levels (1001 +/-267 and 1262 +/-363 pM/ELF, respectively).
Promoter analysis
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In order to determine whether promoter activity of the hIL-18 5'UTR promoter region 
Determination of endotoxin levels in BAL fluid
Given the potent effect of LPS on IL-18 promoter activity and gene and protein expression, we quantified endotoxin levels in sarcoid, recovered patient and normal subject BAL. Sarcoid BAL was found to contain a notably higher level of endotoxin (26.0 EU ± 3.7)
compared to recovered patient BAL (7.7 EU ± 4.3) and healthy control samples (13.5 EU ± 
Effect of the hIL-18 5'UTR -607 C/A SNP on promoter activity
Our previous experiments looking at hIL-18 5'UTR promoter activity used a plasmid that contained an A nucleotide at position -607. Given that the -607 C allele was the most predominant in the sarcoidosis group, it was important to determine if the -607 coli peritonitis (54) . In the present study we have detected the presence of Gram-negative bacterial DNA in active sarcoid BAL however, this bacterial DNA is not the factor responsible for inducing IL-18 expression as DNAse treatment of sarcoid BAL has no effect on IL-18 inducibility (data not shown). IL-18 levels during the active phase of pulmonary sarcoidosis were also shown to be elevated compared to those of recovered patients.
Sarcoidosis is pathologically very similar to CBD -some people have even coined the term "sarcoidosis of known etiology" to describe CBD yet the disorders develop in 13 response to different antigens, and culminate in the development of noncaseating granulomas.
CBD is characterized by a hypersensitivity to beryllium salts and previous studies have shown However BAL from the patients in this study had no previous exposure to beryllium and showed negative cultures and biopsies for tuberculosis infection.
In addition to environmental factors, there is evidence that genetic factors contribute to the pathogenesis of sarcoidosis (1) . Much evidence suggests that genetic variability's in human leukocyte antigen genes play a role in sarcoidosis (60) . 16s rRNA General detection
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Study population
Individuals underwent venipuncture and/or bronchoalveolar lavage (BAL) using a fiberoptic bronchoscope (E1). This was performed using a protocol approved by Beaumont Hospital Ethics Committee. BAL fluid was filtered through three layers of gauze and centrifuged at 300 x g for 10 min. The supernatant was aliquoted and stored at -80°C for further evaluation. The cell pellet was resuspended in 1ml RPMI containing 10% FCS (Life Technologies, Paisley, U.K.). Cells were counted in a hemocytometer, and cytospin slides were prepared for cytology. As the volume of BAL fluid recovered in different disease states may vary, we standardized this by quantifying the volume of ELF recovered by lavage using the urea dilution method (Sigma, Dublin, Ireland.) (E2).
Promoter analysis
THP-1 cells (1 x 10 6 ) were transiently transfected using liposomal mediated DNA transfer (Transfast Transfection reagent, Promega, Southampton, U.K.) in a 1:1 ratio according to the manufacturer's instructions using 1µg of IL-18 5'UTR luciferase plasmid.
Uniform transfection efficiencies were achieved by initially optimising transfection conditions using a constitutive luciferase expression vector, pGL3 control (Promega).
Transfections were incubated at 1 h at 37°C. Cells were then supplemented with additional growth medium (5ml/well) for 24 h at 37°C before being left untreated or stimulated with Tuberculin PPD (5TU, Statens Serum Institut, Denmark) BeSO 4 (100µM, Sigma-Aldrich), LPS (10µg/ml, Pseudomonas aeruginosa, Sigma), 10µl sarcoid or recovered patient ELF.
Twenty-four hours post stimulation the cells were washed with PBS and lysed in reporter lysis buffer (Promega) (100µl/well) and protein concentrations were determined. Luciferase activity in cell lysates was measured using a Wallac Victor 2 1420 Multilabel counter (Turku,   2 Finland) using the Promega luciferase assay system according to the manufacturer's instructions. Reporter gene expression was expressed as light units/µg of total protein.
IL-18 mRNA Analysis
Total RNA was extracted from 1x 10 6 THP-1 cells that had been left untreated or stimulated with Tuberculin PPD (5TU), BeSO 4 (100µM), LPS (10µg/ml), 10µl sarcoid or recovered patient ELF using TRI reagent (Sigma) according to the manufacturer's instructions. IL-18 transcripts were quantified by initially reverse transcribing total RNA (1µg) using the first strand cDNA synthesis kit (Roche Biochemicals, Lewes, East Sussex, U.K.) according to the manufacturer's instructions. 2.5µl of each cDNA was amplified using Twenty five cycles were used to amplify the more abundant GAPDH cDNA. A final extension of 72°C for 10 min completed the PCR. Semiquantitative PCR generated products of 195bp and 211bp for IL-18 and GAPDH respectively. PCR amplicons were run on 1.5%
Tris borate-EDTA agarose gels containing 0.5µg/ml ethidium bromide (Sigma). IL-18 PCR products were analyzed in a semi-quantitative manner by densitometry using the GeneGenius Gel Documentation and Analysis System (Cambridge, UK) and Syngene GeneSnap and GeneTools software.
IL-18 protein production
